BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 29923180)

  • 1. Pre-diagnostic plasma concentrations of Fibrinogen, sGPIIb/IIIa, sP-selectin, sThrombomodulin, Thrombopoietin in relation to cancer risk: Findings from a large prospective study.
    Graf ME; Sookthai D; Johnson T; Schübel R; Maldonado SG; Pletsch-Borba L; Katzke V; Bugert P; Hoffmeister M; Kaaks R; Kühn T
    Int J Cancer; 2018 Dec; 143(11):2659-2667. PubMed ID: 29923180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Fibrinogen and sP-Selectin are Associated with the Risk of Lung Cancer in a Prospective Study.
    Grafetstätter M; Hüsing A; González Maldonado S; Sookthai D; Johnson T; Pletsch-Borba L; Katzke VA; Hoffmeister M; Bugert P; Kaaks R; Kühn T
    Cancer Epidemiol Biomarkers Prev; 2019 Jul; 28(7):1221-1227. PubMed ID: 31015200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological reproducibility of circulating P-Selectin, Thrombopoietin, GPIIb/IIIa and Thrombomodulin over one year.
    Graf ME; Sookthai D; Johnson T; Schübel R; Katzke V; Bugert P; Hoffmeister M; Kaaks R; Kühn T
    Clin Biochem; 2017 Nov; 50(16-17):942-946. PubMed ID: 28571971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombomodulin and Thrombopoietin, Two Biomarkers of Hemostasis, Are Positively Associated with Adherence to the World Cancer Research Fund/American Institute for Cancer Research Recommendations for Cancer Prevention in a Population-Based Cross-Sectional Study.
    Grafetstätter M; Pletsch-Borba L; Sookthai D; Karavasiloglou N; Johnson T; Katzke VA; Hoffmeister M; Bugert P; Kaaks R; Kühn T
    Nutrients; 2019 Sep; 11(9):. PubMed ID: 31484340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating 25-Hydroxyvitamin D Concentration and Risk of Breast, Prostate, and Colorectal Cancers: The Melbourne Collaborative Cohort Study.
    Heath AK; Hodge AM; Ebeling PR; Eyles DW; Kvaskoff D; Buchanan DD; Giles GG; Williamson EJ; English DR
    Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):900-908. PubMed ID: 30842127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating liver enzymes and risks of chronic diseases and mortality in the prospective EPIC-Heidelberg case-cohort study.
    Katzke V; Johnson T; Sookthai D; Hüsing A; Kühn T; Kaaks R
    BMJ Open; 2020 Mar; 10(3):e033532. PubMed ID: 32152162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower TSH and higher free thyroxine predict incidence of prostate but not breast, colorectal or lung cancer.
    Chan YX; Knuiman MW; Divitini ML; Brown SJ; Walsh J; Yeap BB
    Eur J Endocrinol; 2017 Oct; 177(4):297-308. PubMed ID: 28684452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular injury biomarkers and stroke risk: A population-based study.
    Pletsch-Borba L; Grafetstätter M; Hüsing A; Johnson T; González Maldonado S; Groß ML; Kloss M; Hoffmeister M; Bugert P; Kaaks R; Kühn T
    Neurology; 2020 Jun; 94(22):e2337-e2345. PubMed ID: 32371447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum total thiol levels and the risk of lung, colorectal, breast and prostate cancer: A prospective case-cohort study.
    Gào X; Wilsgaard T; Jansen EHJM; Xuan Y; Anusruti A; Brenner H; Schöttker B
    Int J Cancer; 2020 Mar; 146(5):1261-1267. PubMed ID: 31125113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet activation, coagulation and angiogenesis in breast and prostate carcinoma.
    Caine GJ; Lip GY; Stonelake PS; Ryan P; Blann AD
    Thromb Haemost; 2004 Jul; 92(1):185-90. PubMed ID: 15213860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased soluble P-selectin in patients with haematological and breast cancer: a comparison with fibrinogen, plasminogen activator inhibitor and von Willebrand factor.
    Blann AD; Gurney D; Wadley M; Bareford D; Stonelake P; Lip GY
    Blood Coagul Fibrinolysis; 2001 Jan; 12(1):43-50. PubMed ID: 11229826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treg-Mediated Immune Tolerance and the Risk of Solid Cancers: Findings From EPIC-Heidelberg.
    Barth SD; Schulze JJ; Kühn T; Raschke E; Hüsing A; Johnson T; Kaaks R; Olek S
    J Natl Cancer Inst; 2015 Nov; 107(11):. PubMed ID: 26298011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folate levels and cancer morbidity and mortality: prospective cohort study from Busselton, Western Australia.
    Rossi E; Hung J; Beilby JP; Knuiman MW; Divitini ML; Bartholomew H
    Ann Epidemiol; 2006 Mar; 16(3):206-12. PubMed ID: 16343942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of PDGF-AB and sP-selectin concentrations in relation to platelet count in patients with colorectal cancer before and after surgical treatment.
    Mantur M; Koper O; Snarska J; Sidorska A; Kruszewska-Wnorowska K
    Pol Arch Med Wewn; 2008 Jun; 118(6):345-50. PubMed ID: 18619189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood lipids and lipoproteins in relation to incidence and mortality risks for CVD and cancer in the prospective EPIC-Heidelberg cohort.
    Katzke VA; Sookthai D; Johnson T; Kühn T; Kaaks R
    BMC Med; 2017 Dec; 15(1):218. PubMed ID: 29254484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of soluble P-selectin levels in colorectal cancer.
    Ferroni P; Roselli M; Martini F; D'Alessandro R; Mariotti S; Basili S; Spila A; Aloe S; Palmirotta R; Maggini A; Del Monte G; Mancini R; Graziano F; Cosimelli M; Guadagni F
    Int J Cancer; 2004 Sep; 111(3):404-8. PubMed ID: 15221968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron status in relation to cancer risk and mortality: Findings from a population-based prospective study.
    Quintana Pacheco DA; Sookthai D; Graf ME; Schübel R; Johnson T; Katzke VA; Kaaks R; Kühn T
    Int J Cancer; 2018 Aug; 143(3):561-569. PubMed ID: 29574909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers of Vascular Injury and Type 2 Diabetes: A Prospective Study, Systematic Review and Meta-Analysis.
    Pletsch-Borba L; Watzinger C; Turzanski Fortner R; Katzke V; Schwingshackl L; Sowah SA; Hüsing A; Johnson T; Groß ML; González Maldonado S; Hoffmeister M; Bugert P; Kaaks R; Grafetstätter M; Kühn T
    J Clin Med; 2019 Nov; 8(12):. PubMed ID: 31783601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential role of soluble CD40 ligand as inflammatory biomarker in colorectal cancer patients.
    Dymicka-Piekarska V; Korniluk A; Gryko M; Siergiejko E; Kemona H
    Int J Biol Markers; 2014 Sep; 29(3):e261-7. PubMed ID: 24706377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-diagnostic derivatives of reactive oxygen metabolites and the occurrence of lung, colorectal, breast and prostate cancer: An individual participant data meta-analysis of two large population-based studies.
    Gào X; Wilsgaard T; Jansen EH; Holleczek B; Zhang Y; Xuan Y; Anusruti A; Brenner H; Schöttker B
    Int J Cancer; 2019 Jul; 145(1):49-57. PubMed ID: 30561010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.